investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Mechanism of action and therapeutic utility of immunosuppressive oligonucleotide
Dennis Klinman
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Sven Klaschik
University of Bonn
Bonn, Germany
Dennis Klinman
National Cancer Institute (NIH)
Rockville, United States
Related projects
Pier Paolo Pandolfi
Deconstruction and in vivo functionalization of the ceRNA cancer network (PQ-11)
All cancers but non-melanoma skin cancer
Michael Lichten
Mechanism of Meiotic Recombination
All cancers but non-melanoma skin cancer
Renato V Iozzo
The Biology of Perlecan in Cancer and Angiogenesis
All cancers but non-melanoma skin cancer
Nicholas E Baker
Neuronal Cell Cycle and Survival
All cancers but non-melanoma skin cancer
Ruth Nussinov
Method Development: Efficient Computer Vision Based Algorithms
All cancers but non-melanoma skin cancer
Bruce E. Johnson
EGFR Mutations in Non-Small Cell Lung Cancer
Trachea, bronchus and lung
Frank Gonzalez
Xenobiotic Receptors
All cancers but non-melanoma skin cancer
Marc Nicklaus
Fundamentals of Ligand-Protein Interactions – Rockville
All cancers but non-melanoma skin cancer
Peter Kent Jackson
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
Trachea, bronchus and lung